Trials / Completed
CompletedNCT04787510
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- University Hospital, Ioannina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Effect of Covid-19 disease in clotting factors levels in hospitalized patients
Detailed description
Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection. Association between clotting factors levels and disease severity,morbidity and mortality in these patients. Effect of anticoagulant therapy in the clotting factors' levels in these patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | low molecular weight Heparin as standard of care treatment | STANDARD OF CARE |
Timeline
- Start date
- 2020-12-23
- Primary completion
- 2021-05-23
- Completion
- 2021-06-23
- First posted
- 2021-03-08
- Last updated
- 2021-09-28
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT04787510. Inclusion in this directory is not an endorsement.